Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Invested Capital (2023 - 2025)

Historic Invested Capital for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $687.6 million.

  • CG Oncology's Invested Capital rose 2810.76% to $687.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $687.6 million, marking a year-over-year increase of 2810.76%. This contributed to the annual value of $733.4 million for FY2024, which is 69575.71% up from last year.
  • CG Oncology's Invested Capital amounted to $687.6 million in Q3 2025, which was up 2810.76% from $670.4 million recorded in Q2 2025.
  • CG Oncology's Invested Capital's 5-year high stood at $733.4 million during Q4 2024, with a 5-year trough of -$123.1 million in Q4 2023.
  • Moreover, its 3-year median value for Invested Capital was $619.6 million (2024), whereas its average is $541.4 million.
  • Per our database at Business Quant, CG Oncology's Invested Capital soared by 69575.71% in 2024 and then soared by 2136.27% in 2025.
  • CG Oncology's Invested Capital (Quarter) stood at -$123.1 million in 2023, then skyrocketed by 695.76% to $733.4 million in 2024, then fell by 6.24% to $687.6 million in 2025.
  • Its last three reported values are $687.6 million in Q3 2025, $670.4 million for Q2 2025, and $704.8 million during Q1 2025.